Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Ellipsis Health has developed an innovative care management platform powered by AI, featuring its virtual assistant, Sage, which aims to streamline and improve patient engagement through voice interactions that prioritize emotional intelligence while seamlessly fitting into existing clinical processes. Sage is capable of conducting completely autonomous phone conversations in multiple languages with patients, managing various tasks like enrolling in programs, verifying eligibility, checking copays, and responding to inquiries, in addition to carrying out assessments such as health risk evaluations, follow-up communications after discharge, satisfaction surveys, and tracking outcomes. This platform enhances clinical operations by facilitating care coordination, monitoring treatment adherence, and performing check-ins before and after discharges, thus aiding healthcare providers in ensuring uninterrupted care and boosting quality metrics. At the core of this system is an "empathy engine," which evaluates vocal biomarkers—such as tone, pace, and speech patterns—to identify emotional and mental health indicators, thereby providing valuable insights into patient wellbeing. Through these advanced capabilities, Sage not only assists in operational efficiency but also fosters a deeper connection between patients and healthcare practitioners, ultimately contributing to better health outcomes.
Description
Pharmaceutical companies require extensive genomic data to effectively implement precision medicine initiatives; however, they frequently rely on merely 10% of the available information for their decisions. Genomenon provides access to the complete dataset. Their Prodigy™ Patient Landscapes offer a streamlined and economical solution for natural history research, aiding the creation of therapies for rare diseases by deepening understanding of both retrospective and prospective health data. Utilizing an advanced AI-driven methodology, Genomenon conducts a thorough evaluation of each patient documented in the medical literature in a significantly reduced timeframe. Ensure you capture all relevant insights by exploring every genomic biomarker featured in published studies. Each scientific claim is substantiated by concrete evidence drawn from the medical literature, allowing researchers to uncover all genetic drivers and identify variants recognized as pathogenic in accordance with ACMG clinical standards, thereby enhancing the development process of targeted therapies. By leveraging this comprehensive approach, pharma companies can enhance their research effectiveness and ultimately improve patient outcomes.
API Access
Has API
API Access
Has API
Integrations
Google Cloud Platform
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Ellipsis Health
Founded
2017
Country
United States
Website
ellipsishealth.com
Vendor Details
Company Name
Genomenon
Country
United States
Website
www.genomenon.com/pharma/